27 September 2023 in American Journal of Transplantation
Atypical anti-glomerular basement membrane (GBM) nephritis can be defined as linear GBM staining for monotypic or polytypic immunoglobulin (Ig) by immunofluorescence (IF) without a diffuse crescentic pattern. We describe the clinicopathologic features of 6 patients (18 biopsies) in this first series of recurrent atypical anti-GBM nephritis in the transplant. Recurrent glomerulonephritis occurred at a mean of 3.8 months post-transplant (range 1-7 months). 3 index biopsies were for clinical indication and 3 were protocol biopsies. Glomerular histologic changes were mild, with 2 showing segmental endocapillary hypercellularity, one focal glomerular microangiopathy, and the others no significant glomerular histologic changes. All 6 allografts showed monotypic linear glomerular Ig staining by IF: IgG kappa (n=2), IgG lambda, IgA kappa, IgA lambda, and IgM lambda. Follow up biopsies were available for 5 patients and showed similar histologic and IF findings, without evidence of significant progression. No patients had detectable serum anti-GBM or monoclonal proteins. The mean serum creatinine on follow up (24-62 months post-transplant) was 1.8 mg/dL (range 0.93 - 2.77 mg/dL); no grafts were lost to recurrent disease. This series demonstrates that monotypic atypical anti-GBM recurs in the allograft and supports that this disease is due to a circulating monoclonal protein.
10 May 2020 in International Journal of Surgical Pathology
Vascular transformation of the lymph node sinuses (VTS) is an uncommon phenomenon that is believed to occur secondary to obstruction of efferent lymphatics, frequently occuring in retroperitoneal lymph nodes draining cancer. The nodular subtype of VTS, in particular, can mimic metastatic cancer, such as metastatic renal cell carcinoma with sarcomatoid differentiation, potentially resulting in inaccurate tumor grading and/or staging. We present a case of nodular VTS mimicking metastatic renal cell carcinoma with sarcomatoid differentiation in a patient with high-grade clear cell renal cell carcinoma, and explore the relevant differential diagnosis. Awareness of VTS is essential to avoid misdiagnosis of this benign and curative condition.